Detection of Macrophages in Aortic Aneurysms by Nanoparticle Positron Emission Tomography–Computed Tomography
Author(s) -
Matthias Nahrendorf,
Edmund J. Keliher,
Brett Marinelli,
Florian Leuschner,
Clinton S. Robbins,
Robert E. Gerszten,
Mikaël J. Pittet,
Filip K. Świrski,
Ralph Weissleder
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.221499
Subject(s) - positron emission tomography , macrophage , inflammation , in vivo , aorta , monocyte , flow cytometry , medicine , molecular imaging , ex vivo , pathology , tomography , radiology , nuclear medicine , chemistry , in vitro , biology , immunology , biochemistry , microbiology and biotechnology
Current management of aortic aneurysms (AAs) relies primarily on size criteria to determine whether invasive repair is indicated to preempt rupture. We hypothesized that emerging molecular imaging tools could be used to more sensitively gauge local inflammation. Because macrophages are key effector cells that destabilize the extracellular matrix in the arterial wall, it seemed likely that they would represent suitable imaging targets. We here aimed to develop and validate macrophage-targeted nanoparticles labeled with fluorine-18 ((18)F) for positron emission tomography-computed tomography (PET-CT) detection of inflammation in AAs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom